Market Forecast By Drug Type (Prescription Drugs, OTC Drugs), By Type ( Community Pharmacy, Hospital Pharmacy, Clinical Pharmacy, Industrial Pharmacy, Compounding Pharmacy, Consulting Pharmacy, Ambulatory Care Pharmacy, Others) And Competitive Landscape
Product Code: ETC036143 | Publication Date: Jun 2023 | Updated Date: Nov 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Report Name | Mexico Pharmacies and Drug Stores market |
Forecast period | 2025-2031 |
Forecast size | USD 30 Billion – USD 50 Billion |
CAGR | 6.9% |
Growing Sector | Healthcare |
The Mexico Pharmacies and Drug Stores market report thoroughly covers the market by drug type and by type. The report provides an unbiased and detailed analysis of the on-going market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
In 2024, the Mexico Pharmacies and Drug Stores market is valued at approximately $ 30 billion, with a projected compound annual growth rate (CAGR) of 6.9% over the next five years. Additionally, by 2030, the market is expected to reach around $ 50 billion. The healthcare sector holds significant position in the overall market.
The Mexico pharmacies and drug stores market is experiencing steady growth, driven by an expanding healthcare sector, increasing consumer awareness about health and wellness, and the rising prevalence of chronic diseases. Pharmacies and drug stores in Mexico are becoming more integral to the healthcare landscape, offering a range of services beyond medication dispensing, such as health consultations, vaccinations, and diagnostics. The market benefits from the growing middle class, an aging population, and the expansion of both physical and online pharmacy services. Additionally, Mexico’s proximity to the U.S. facilitates access to a diverse range of pharmaceutical products, contributing to the market’s dynamism.
According to 6Wresearch, Mexico Pharmacies and Drug Stores market size is projected to grow at a CAGR of 6.9% during 2025-2031. The growth of the Mexico pharmacies and drug stores market is driven by several key factors, including the increasing demand for pharmaceuticals due to an aging population, higher rates of chronic diseases such as diabetes and hypertension, and greater consumer health awareness. The expansion of pharmacy chains and the rise of online pharmacies have made medications more accessible to the population. Additionally, higher government spending on healthcare infrastructure and reforms aimed at expanding health coverage are supporting market growth. However, challenges include regulatory hurdles and the ongoing pressure to control drug pricing, which affects profit margins for drugstores. The informal market for medicines, especially unregulated and counterfeit drugs, poses another challenge to the industry’s growth. Furthermore, economic fluctuations and inflation can impact consumer spending on non-essential health products, slowing down market expansion.
Key companies in the Mexico pharmacies and drug stores market include major players such as Farmacias del Ahorro, one of the largest pharmacy chains in Mexico, offering a broad range of pharmaceutical and healthcare products across the country. Farmacias similares is another leading chain, known for providing affordable generic medicines and expanding its presence in both urban and rural areas. CVS Pharmacy and Walgreens also have a significant footprint in the market through their international operations and partnerships.
Additionally, Grupo Fármacos Especializados operates as a leading player in the distribution of high-quality specialty drugs, while San Pablo is a prominent player known for its network of pharmacies and its role in retail health services. Additionally, some of these players hold majority of the Mexico Pharmacies and Drug Stores market share. Moreover, these companies dominate the market with their extensive networks, strategic expansions, and collaborations with healthcare providers.
In Mexico, the pharmacies and drug stores market is heavily regulated by government entities to ensure the safety, efficacy, and quality of pharmaceutical products. The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the primary regulatory authority overseeing the pharmaceutical sector, enforcing regulations on the manufacturing, importation, distribution, and sale of drugs. The General Health Law and Pharmaceutical Law set stringent guidelines for the operation of pharmacies, including the requirement for licensed pharmacists to manage the sale of prescription drugs. Further, these initiatives have further boosted the Mexico Pharmacies and Drug Stores market revenues.
Furthermore, COFEPRIS ensures compliance with Good Manufacturing Practices (GMP) and the safety standards for over-the-counter and prescription medications. Additionally, there are regulations related to advertising, pricing, and the labeling of drugs, ensuring that consumers have access to transparent and safe pharmaceutical products. These regulations aim to protect public health, ensure the availability of quality medications, and combat the sale of counterfeit drugs.
The future of the Mexico pharmacies and drug stores market looks promising, with significant growth expected in the coming years. The increasing adoption of digital technologies, such as e-commerce and telemedicine, is reshaping the landscape, allowing pharmacies to offer online prescriptions, home delivery services, and virtual consultations. With a growing aging population and increasing healthcare awareness, demand for both prescription and over-the-counter drugs is likely to rise. Additionally, the market will benefit from rising consumer preferences for wellness products, natural remedies, and personalized medicines.
However, challenges related to price regulations, competition from international players, and the need for continued compliance with stringent government regulations will persist. As such, companies focusing on digital transformation, expanding their services, and ensuring product safety and affordability will likely capitalize on future market opportunities.
According to Ravi Bhandari, Research Head, 6Wresearch, the prescription drugs category in Mexico's pharmacies and drug stores market is expected to see substantial growth due to an aging population, increasing prevalence of chronic diseases, and greater healthcare access. The demand for prescription medications is being driven by rising healthcare awareness, higher doctor consultations, and the expansion of insurance coverage. Additionally, the growing focus on specialized treatments, such as biologics and personalized medicines, is contributing to the sector’s expansion. However, challenges such as regulatory scrutiny, pricing controls, and competition from generic drug manufacturers may moderate growth. Despite these obstacles, the prescription drugs category remains a key driver of revenue for pharmacies and drug stores in Mexico.
The hospital pharmacy segment in Mexico is witnessing significant growth, driven by the increasing demand for specialized medical treatments and a rise in hospital admissions. As healthcare infrastructure improves and more people gain access to hospital care, hospital pharmacies are becoming crucial in providing medication management, dispensing services, and ensuring proper dosage and administration of medicines. The growing prevalence of complex diseases, such as cancer and cardiovascular conditions, is also contributing to the demand for specialized pharmaceutical services in hospitals. Additionally, advancements in hospital-based technologies and systems are enabling more efficient pharmacy operations, further accelerating growth in this segment.
The Mexico Pharmacies and Drug Stores market report provides a detailed analysis of the following market segments -
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Pharmacies and Drug Stores Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Pharmacies and Drug Stores Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Pharmacies and Drug Stores Market - Industry Life Cycle |
3.4 Mexico Pharmacies and Drug Stores Market - Porter's Five Forces |
3.5 Mexico Pharmacies and Drug Stores Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Mexico Pharmacies and Drug Stores Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Mexico Pharmacies and Drug Stores Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mexico Pharmacies and Drug Stores Market Trends |
6 Mexico Pharmacies and Drug Stores Market, By Types |
6.1 Mexico Pharmacies and Drug Stores Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Drug Type, 2021-2031F |
6.1.3 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Prescription Drugs, 2021-2031F |
6.1.4 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By OTC Drugs, 2021-2031F |
6.2 Mexico Pharmacies and Drug Stores Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Community Pharmacy, 2021-2031F |
6.2.3 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.4 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Clinical Pharmacy, 2021-2031F |
6.2.5 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Industrial Pharmacy, 2021-2031F |
6.2.6 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Compounding Pharmacy, 2021-2031F |
6.2.7 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Consulting Pharmacy, 2021-2031F |
6.2.8 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
6.2.9 Mexico Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2021-2031F |
7 Mexico Pharmacies and Drug Stores Market Import-Export Trade Statistics |
7.1 Mexico Pharmacies and Drug Stores Market Export to Major Countries |
7.2 Mexico Pharmacies and Drug Stores Market Imports from Major Countries |
8 Mexico Pharmacies and Drug Stores Market Key Performance Indicators |
9 Mexico Pharmacies and Drug Stores Market - Opportunity Assessment |
9.1 Mexico Pharmacies and Drug Stores Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Mexico Pharmacies and Drug Stores Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Mexico Pharmacies and Drug Stores Market - Competitive Landscape |
10.1 Mexico Pharmacies and Drug Stores Market Revenue Share, By Companies, 2024 |
10.2 Mexico Pharmacies and Drug Stores Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |